Auto - Parts
Compare Stocks
2 / 10Stock Comparison
DORM vs BWA
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Parts
DORM vs BWA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Auto - Parts | Auto - Parts |
| Market Cap | $3.72B | $12.05B |
| Revenue (TTM) | $2.15B | $14.33B |
| Net Income (TTM) | $190M | $362M |
| Gross Margin | 40.7% | 18.9% |
| Operating Margin | 15.6% | 9.6% |
| Forward P/E | 15.0x | 11.3x |
| Total Debt | $633M | $4.18B |
| Cash & Equiv. | $49M | $2.31B |
DORM vs BWA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Dorman Products, In… (DORM) | 100 | 178.1 | +78.1% |
| BorgWarner Inc. (BWA) | 100 | 205.7 | +105.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DORM vs BWA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DORM carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.85
- Rev growth 6.0%, EPS growth 8.1%, 3Y rev CAGR 7.1%
- 129.7% 10Y total return vs BWA's 114.1%
BWA is the clearest fit if your priority is value and dividends.
- Lower P/E (11.3x vs 15.0x)
- 0.9% yield; 1-year raise streak; the other pay no meaningful dividend
- +94.2% vs DORM's +0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.0% revenue growth vs BWA's 1.7% | |
| Value | Lower P/E (11.3x vs 15.0x) | |
| Quality / Margins | 8.8% margin vs BWA's 2.5% | |
| Stability / Safety | Beta 0.85 vs BWA's 1.01, lower leverage | |
| Dividends | 0.9% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +94.2% vs DORM's +0.5% | |
| Efficiency (ROA) | 7.6% ROA vs BWA's 2.6%, ROIC 13.9% vs 12.9% |
DORM vs BWA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DORM vs BWA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DORM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BWA is the larger business by revenue, generating $14.3B annually — 6.7x DORM's $2.2B. DORM is the more profitable business, keeping 8.8% of every revenue dollar as net income compared to BWA's 2.5%. On growth, DORM holds the edge at +4.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.2B | $14.3B |
| EBITDAEarnings before interest/tax | $377M | $1.9B |
| Net IncomeAfter-tax profit | $190M | $362M |
| Free Cash FlowCash after capex | $71M | $1.6B |
| Gross MarginGross profit ÷ Revenue | +40.7% | +18.9% |
| Operating MarginEBIT ÷ Revenue | +15.6% | +9.6% |
| Net MarginNet income ÷ Revenue | +8.8% | +2.5% |
| FCF MarginFCF ÷ Revenue | +3.3% | +11.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.2% | +0.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -23.5% | +61.1% |
Valuation Metrics
BWA leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 18.8x trailing earnings, DORM trades at a 59% valuation discount to BWA's 45.5x P/E. On an enterprise value basis, BWA's 6.8x EV/EBITDA is more attractive than DORM's 10.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.7B | $12.0B |
| Enterprise ValueMkt cap + debt − cash | $4.3B | $13.9B |
| Trailing P/EPrice ÷ TTM EPS | 18.75x | 45.45x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.05x | 11.28x |
| PEG RatioP/E ÷ EPS growth rate | 1.25x | — |
| EV / EBITDAEnterprise value multiple | 10.41x | 6.81x |
| Price / SalesMarket cap ÷ Revenue | 1.75x | 0.84x |
| Price / BookPrice ÷ Book value/share | 2.59x | 2.24x |
| Price / FCFMarket cap ÷ FCF | 49.18x | 10.22x |
Profitability & Efficiency
DORM leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
DORM delivers a 13.1% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $6 for BWA. DORM carries lower financial leverage with a 0.43x debt-to-equity ratio, signaling a more conservative balance sheet compared to BWA's 0.74x. On the Piotroski fundamental quality scale (0–9), BWA scores 8/9 vs DORM's 7/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +13.1% | +6.2% |
| ROA (TTM)Return on assets | +7.6% | +2.6% |
| ROICReturn on invested capital | +13.9% | +12.9% |
| ROCEReturn on capital employed | +18.5% | +12.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.43x | 0.74x |
| Net DebtTotal debt minus cash | $584M | $1.9B |
| Cash & Equiv.Liquid assets | $49M | $2.3B |
| Total DebtShort + long-term debt | $633M | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | 8.24x | 10.46x |
Total Returns (Dividends Reinvested)
BWA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BWA five years ago would be worth $12,873 today (with dividends reinvested), compared to $11,922 for DORM. Over the past 12 months, BWA leads with a +94.2% total return vs DORM's +0.5%. The 3-year compound annual growth rate (CAGR) favors BWA at 14.7% vs DORM's 12.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +0.3% | +25.1% |
| 1-Year ReturnPast 12 months | +0.5% | +94.2% |
| 3-Year ReturnCumulative with dividends | +41.6% | +50.8% |
| 5-Year ReturnCumulative with dividends | +19.2% | +28.7% |
| 10-Year ReturnCumulative with dividends | +129.7% | +114.1% |
| CAGR (3Y)Annualised 3-year return | +12.3% | +14.7% |
Risk & Volatility
Evenly matched — DORM and BWA each lead in 1 of 2 comparable metrics.
Risk & Volatility
DORM is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than BWA's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BWA currently trades 83.0% from its 52-week high vs DORM's 74.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.85x | 1.01x |
| 52-Week HighHighest price in past year | $166.89 | $70.08 |
| 52-Week LowLowest price in past year | $98.44 | $29.41 |
| % of 52W HighCurrent price vs 52-week peak | +74.6% | +83.0% |
| RSI (14)Momentum oscillator 0–100 | 71.2 | 65.7 |
| Avg Volume (50D)Average daily shares traded | 273K | 2.3M |
Analyst Outlook
DORM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates DORM as "Buy" and BWA as "Buy". Consensus price targets imply 18.3% upside for BWA (target: $69) vs 12.4% for DORM (target: $140). BWA is the only dividend payer here at 0.95% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $140.00 | $68.80 |
| # AnalystsCovering analysts | 16 | 38 |
| Dividend YieldAnnual dividend ÷ price | — | +0.9% |
| Dividend StreakConsecutive years of raises | 2 | 1 |
| Dividend / ShareAnnual DPS | — | $0.55 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +4.2% |
DORM leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BWA leads in 2 (Valuation Metrics, Total Returns). 1 tied.
DORM vs BWA: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is DORM or BWA a better buy right now?
For growth investors, Dorman Products, Inc.
(DORM) is the stronger pick with 6. 0% revenue growth year-over-year, versus 1. 7% for BorgWarner Inc. (BWA). Dorman Products, Inc. (DORM) offers the better valuation at 18. 8x trailing P/E (15. 0x forward), making it the more compelling value choice. Analysts rate Dorman Products, Inc. (DORM) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DORM or BWA?
On trailing P/E, Dorman Products, Inc.
(DORM) is the cheapest at 18. 8x versus BorgWarner Inc. at 45. 5x. On forward P/E, BorgWarner Inc. is actually cheaper at 11. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — DORM or BWA?
Over the past 5 years, BorgWarner Inc.
(BWA) delivered a total return of +28. 7%, compared to +19. 2% for Dorman Products, Inc. (DORM). Over 10 years, the gap is even starker: DORM returned +129. 7% versus BWA's +114. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DORM or BWA?
By beta (market sensitivity over 5 years), Dorman Products, Inc.
(DORM) is the lower-risk stock at 0. 85β versus BorgWarner Inc. 's 1. 01β — meaning BWA is approximately 19% more volatile than DORM relative to the S&P 500. On balance sheet safety, Dorman Products, Inc. (DORM) carries a lower debt/equity ratio of 43% versus 74% for BorgWarner Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DORM or BWA?
By revenue growth (latest reported year), Dorman Products, Inc.
(DORM) is pulling ahead at 6. 0% versus 1. 7% for BorgWarner Inc. (BWA). On earnings-per-share growth, the picture is similar: Dorman Products, Inc. grew EPS 8. 1% year-over-year, compared to -14. 7% for BorgWarner Inc.. Over a 3-year CAGR, DORM leads at 7. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DORM or BWA?
Dorman Products, Inc.
(DORM) is the more profitable company, earning 9. 6% net margin versus 1. 9% for BorgWarner Inc. — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DORM leads at 16. 8% versus 9. 2% for BWA. At the gross margin level — before operating expenses — DORM leads at 41. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DORM or BWA more undervalued right now?
On forward earnings alone, BorgWarner Inc.
(BWA) trades at 11. 3x forward P/E versus 15. 0x for Dorman Products, Inc. — 3. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BWA: 18. 3% to $68. 80.
08Which pays a better dividend — DORM or BWA?
In this comparison, BWA (0.
9% yield) pays a dividend. DORM does not pay a meaningful dividend and should not be held primarily for income.
09Is DORM or BWA better for a retirement portfolio?
For long-horizon retirement investors, BorgWarner Inc.
(BWA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01), 0. 9% yield, +114. 1% 10Y return). Both have compounded well over 10 years (BWA: +114. 1%, DORM: +129. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DORM and BWA?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
BWA pays a dividend while DORM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.